MyoDish Tissue Culture System

• Long-term culture of human and animal myocardial tissue up to several weeks
• Basic and Translational Cardiac Research, Drug and Toxicity Screening, Tissue Engineering, Stem Cell Research, Teaching
• Developped by scientists for scientists. The device has been used in many high-impact publications. See references below.
• Download flyer here

• For a quote, send an email to sales@invitrosys.com, for general inquiries to info@invitrosys.com

MyoDish 1 Tissue Culture System

MyoDish Tester

• Calibration of culture chambers to obtain precise force read-outs

Essential Medium Heater

From our and customer experience, maintaining the culture medium (and the tissue slices) at body temperature during medium exchanges
is essential for successful cardiac tissue culture. That is why we developed the Essential Medium Heater.
• Dry block heater for 2x 50 ml tubes that keeps culture medium at 37° C on the laminar flow bench
• Can be used as a dry bath to heat up cold medium
• Ergonomic handling thanks to small dimensions and minimalist design, reduces strain
• Recommended also for cell culture !

References

• Fischer et al., 2019, Nature Communications
• Moretti et al., 2020, Nature Medicine
• Bojkova et al., 2020, Cardiovascular Research
• Abu-Khousa et al., 2020, Frontiers in Physiology
• Lu et al., 2021, Theranostics
• Krane et al., 2021, Circulation
• Esfandyari et al., 2022, Nature Communications
• Klumm et al., 2022, Frontiers in Physiology
• Poch et al., 2022, Nature Cell Biology
• Hamers et al., 2022, Journal of Visual Experiments
• Waleczek et al., 2022, Basic Research in Cardiology
• Cao-Ehlker et al., 2023, Bioengineering (Basel)
• Amesz et al., 2023, Cardiovascular Drugs and Therapy
• Amesz et al., 2023, Scientific Reports
• Pfeuffer et al., 2023, International Journal of Molecular Sciences
• Abbas et al., 2024, European Heart Journal
• Baron et al., 2024, Frontiers in Bioengineering and Biotechnology
• Sun et al., 2024, Communications Biology
• Amesz et al., 2024, Biomedicine & Pharmacotherapy
• Walaczek et al., 2024, International Journal of Molecular Sciences
• Bierhuizen et al., 2025, Bioengineering
• Krammer et al., 2025, European Journal of Heart Failure
• van der Geest et al., 2025, JHLT Open
• Bentele et al., 2025, Scientific Reports
• van der Geest et al., 2025, British Journal of Pharmacology
• Kiselev et al., 2025, British Journal of Pharmacology
• Chan et al., 2025, Nature Cardiovascular Research
• Nassar et al., 2026, iScience

Newsletter

Subscribe to get information on software updates, new products and SOPs
Please use an email address from your affiliation. We cannot accept gmail, gmx, etc.

By submitting this form, you agree that InVitroSys GmbH may use and store your email address to send you product updates, software updates and SOPs by email. You can unsubscribe at any time with effect for the future. Further information on the processing of your data can be found in the Privacy Notice.

Downloads

• MyoDish Data File Converter v1.1
• Slicing Buffer
• Assembly Of Culture Chambers
• Cleaning of Culture Chambers and Electrodes
• Schedule File Manual

Contact

InVitroSys GmbH
Henkestr. 91
91052 Erlangen
Germany

info@invitrosys.com

Privacy Notice

Controller: InVitroSys GmbH, Henkestr. 91, 91052 Erlangen, Germany, info@invitrosys.com

If you subscribe to our mailing list, we process your email address in order to send you information about product updates, software updates and SOPs by email.

Legal basis: your consent.

We store your email address until you unsubscribe or until the mailing list is discontinued. You can withdraw your consent at any time with effect for the future by using the unsubscribe option in the form or by emailing us at updates@invitrosys.com.

Your data will only be used for the mailing list and will not be used for other purposes without your consent. You have the right to request information about your personal data, rectification, erasure, restriction of processing and, where applicable, data portability, subject to the statutory requirements.

Impressum

Geschäftsführer und inhaltlich verantwortlich gemäß § 55 Abs. 2 RStV:
Dr. Andreas Dendorfer, Dr. Thomas Seidel
Umsatzsteuer-ID: DE332912832
Steuernummer: 143/150/82138
Registergericht: Amtsgericht Fürth, HRB 22431